Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
ConditionLiver Cirrhosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorUniversity Hospital, Bonn
About this trial
The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.
Eligibility criteria
Qualifiers
liver cirrhosis of any etiology
CT scan available
Disqualifiers
HCC or any malignant disease
Trial design
Treatments tested in this trial
- imaging
Treatment groups
No treatment groups listed
Sponsors and collaborators
University Hospital, Bonn
Lead sponsor
University of Roma La Sapienza
Collaborator
Source ClinicalTrials.gov